Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

This study has been completed.
Sponsor:
Information provided by:
Tuscaloosa Research & Education Advancement Corporation
ClinicalTrials.gov Identifier:
NCT00233467
First received: October 3, 2005
Last updated: September 20, 2006
Last verified: September 2006

October 3, 2005
September 20, 2006
September 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00233467 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year’s worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient’s with PTSD over the last 10 years.

This study is a retrospective chart review of patients, at the Tuscaloosa VA Medical Center, who were, treated with antipsychotics as monotherapy or adjunctive therapy.

The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten year’s worth of data. Charts will then be examined to determine what type of antipsychotics patients were prescribed, the dose and duration of the antipsychotics, and the presence or absence of documented psychotic symptoms.

Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
  • PTSD
  • Posttraumatic Stress Disorder
Not Provided
Not Provided
Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry. 2005 Jul;66(7):922-7.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
September 2005
Not Provided

Inclusion Criteria:

  1. Have a diagnosis of PTSD (309.81)
  2. Male or female patients at least 19 years of age

Exclusion Criteria:

• None

Both
19 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00233467
TREAC Retro PTSD
Not Provided
Not Provided
Tuscaloosa Research & Education Advancement Corporation
Not Provided
Principal Investigator: Rebecca Seamans, PharmD Tuscaloosa VA Medical Center
Tuscaloosa Research & Education Advancement Corporation
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP